Literature DB >> 31341804

Mode of delivery, birth weight and the incidence of congenital nasolacrimal duct obstruction.

Ayse Dolar Bilge1.   

Abstract

AIM: To study any possible association of congenital nasolacrimal duct obstruction (CNLDO) with mode of delivery, birth weight and gestational age.
METHODS: We retrospectively reviewed charts of all patients (n=2591) under the age of 3y who were born between April 2015 and May 2017 and were examined at the Ophthalmology Clinic of Emsey Hospital Istanbul, Turkey. We identified patients (n=105) who were diagnosed as CNLDO. The mode of delivery, birth weight and gestational age along with any adverse event during or after delivery or any other health history were determined. Birth statistical data were obtained from the hospital's medical records database.
RESULTS: Gestational age of babies who were born via cesarean section (CS) was lower than gestational age of babies who were born via normal spontaneous vaginal delivery (NSVD; P=0.002). Babies who were born via CS were found to have 3.75 times higher risk of developing NLDO when compared to babies who were born via NSVD (OR=3.754).
CONCLUSION: There is a possible association between CS and CNLDO.

Entities:  

Keywords:  cesarian section; congenital nasolacrimal duct obstruction; normal spontaneous vaginal delivery

Year:  2019        PMID: 31341804      PMCID: PMC6629793          DOI: 10.18240/ijo.2019.07.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  2 in total

1.  Success rates of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Marta Świerczyńska; Ewelina Tobiczyk; Piotr Rodak; Dorota Barchanowska; Erita Filipek
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

2.  Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing.

Authors:  Deniz Kilic; Ismail Aydin; Muhammed Rasit Sirem; Hatice Birgin; Soner Guven
Journal:  Beyoglu Eye J       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.